Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS)
CNY 8.14
(0.0%)
CNY 8.14
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 173.9 Million CNY | 5.77% |
| 2022 | 164.42 Million CNY | -17.18% |
| 2021 | 198.53 Million CNY | 4.29% |
| 2020 | 190.36 Million CNY | 23.38% |
| 2019 | 154.28 Million CNY | 36.89% |
| 2018 | 112.7 Million CNY | 42.98% |
| 2017 | 78.82 Million CNY | 4.11% |
| 2016 | 75.71 Million CNY | 17.31% |
| 2015 | 64.54 Million CNY | 2.08% |
| 2014 | 63.22 Million CNY | 54.88% |
| 2013 | 40.82 Million CNY | 26.35% |
| 2012 | 32.3 Million CNY | 120.23% |
| 2011 | 14.67 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 23.71 Million CNY | -39.02% |
| 2024 Q1 | 37.5 Million CNY | -31.89% |
| 2024 Q2 | 38.88 Million CNY | 3.67% |
| 2023 Q3 | 25.06 Million CNY | -51.76% |
| 2023 Q4 | 55.07 Million CNY | 119.68% |
| 2023 FY | 173.9 Million CNY | 5.77% |
| 2023 Q1 | 41.79 Million CNY | -16.2% |
| 2023 Q2 | 51.97 Million CNY | 24.34% |
| 2022 FY | 164.42 Million CNY | -17.18% |
| 2022 Q3 | 39.75 Million CNY | -3.51% |
| 2022 Q4 | 49.87 Million CNY | 25.46% |
| 2022 Q2 | 41.2 Million CNY | 22.64% |
| 2022 Q1 | 33.59 Million CNY | -42.24% |
| 2021 Q2 | 39.07 Million CNY | -28.79% |
| 2021 Q1 | 54.86 Million CNY | -19.95% |
| 2021 Q3 | 46.43 Million CNY | 18.86% |
| 2021 Q4 | 58.16 Million CNY | 25.25% |
| 2021 FY | 198.53 Million CNY | 4.29% |
| 2020 Q1 | 31.18 Million CNY | 6.59% |
| 2020 FY | 190.36 Million CNY | 23.38% |
| 2020 Q3 | 44.42 Million CNY | -3.85% |
| 2020 Q4 | 68.53 Million CNY | 54.26% |
| 2020 Q2 | 46.2 Million CNY | 48.16% |
| 2019 Q1 | 32.13 Million CNY | 24.5% |
| 2019 FY | 154.28 Million CNY | 36.89% |
| 2019 Q4 | 29.25 Million CNY | -21.28% |
| 2019 Q3 | 37.16 Million CNY | -33.3% |
| 2019 Q2 | 55.72 Million CNY | 73.4% |
| 2018 Q1 | 21.49 Million CNY | -20.57% |
| 2018 Q2 | 34.34 Million CNY | 59.72% |
| 2018 Q4 | 25.81 Million CNY | -16.89% |
| 2018 Q3 | 31.05 Million CNY | -9.56% |
| 2018 FY | 112.7 Million CNY | 42.98% |
| 2017 Q4 | 27.06 Million CNY | 39.58% |
| 2017 Q1 | 15.67 Million CNY | -38.66% |
| 2017 Q2 | 16.69 Million CNY | 6.48% |
| 2017 Q3 | 19.39 Million CNY | 16.16% |
| 2017 FY | 78.82 Million CNY | 4.11% |
| 2016 Q2 | 21.77 Million CNY | 44.87% |
| 2016 Q4 | 25.55 Million CNY | 91.35% |
| 2016 Q3 | 13.35 Million CNY | -38.65% |
| 2016 Q1 | 15.02 Million CNY | 0.0% |
| 2016 FY | 75.71 Million CNY | 17.31% |
| 2015 FY | 64.54 Million CNY | 2.08% |
| 2014 Q2 | 13.59 Million CNY | 0.0% |
| 2014 FY | 63.22 Million CNY | 54.88% |
| 2014 Q1 | 13.59 Million CNY | 0.0% |
| 2013 FY | 40.82 Million CNY | 26.35% |
| 2012 FY | 32.3 Million CNY | 120.23% |
| 2011 FY | 14.67 Million CNY | 0.0% |